| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |